Passage Bio Stock Forecast - Simple Regression
| PASG Stock | USD 0.62 0.11 21.57% |
The Simple Regression forecasted value of Passage Bio on the next trading day is expected to be 0.55 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.46. Passage Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Passage Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
Passage |
Passage Bio Simple Regression Price Forecast For the 27th of November
Given 90 days horizon, the Simple Regression forecasted value of Passage Bio on the next trading day is expected to be 0.55 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.46.Please note that although there have been many attempts to predict Passage Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Passage Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Passage Bio Stock Forecast Pattern
| Backtest Passage Bio | Passage Bio Price Prediction | Buy or Sell Advice |
Passage Bio Forecasted Value
In the context of forecasting Passage Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Passage Bio's downside and upside margins for the forecasting period are 0.01 and 6.82, respectively. We have considered Passage Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Passage Bio stock data series using in forecasting. Note that when a statistical model is used to represent Passage Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.0056 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0403 |
| MAPE | Mean absolute percentage error | 0.0649 |
| SAE | Sum of the absolute errors | 2.4598 |
Predictive Modules for Passage Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Passage Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Passage Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Passage Bio
For every potential investor in Passage, whether a beginner or expert, Passage Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Passage Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Passage. Basic forecasting techniques help filter out the noise by identifying Passage Bio's price trends.Passage Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Passage Bio stock to make a market-neutral strategy. Peer analysis of Passage Bio could also be used in its relative valuation, which is a method of valuing Passage Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Passage Bio Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Passage Bio's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Passage Bio's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Passage Bio Market Strength Events
Market strength indicators help investors to evaluate how Passage Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Passage Bio shares will generate the highest return on investment. By undertsting and applying Passage Bio stock market strength indicators, traders can identify Passage Bio entry and exit signals to maximize returns.
Passage Bio Risk Indicators
The analysis of Passage Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Passage Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting passage stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.9 | |||
| Standard Deviation | 6.37 | |||
| Variance | 40.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Passage Bio to cross-verify your projections. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.34) | Return On Equity (0.64) |
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.